ZENA:NASDAQZenaTech, Inc. Analysis
Data as of 2026-09-15 - not real-time
$1.42
Latest Price
9/10Risk
Risk Level: High
Executive Summary
ZenaTech, Inc. is priced at $1.42, and its moving averages give no clean directional read — the structure is neutral. Over a rolling month the price has gained 12.2%. Momentum indicators put RSI at 36.2 (approaching oversold) with MACD reading bearish. The recent range runs from support at $1.40 up to resistance at $2.19.
The company is not currently profitable on a trailing basis, so earnings multiples offer no valuation support. Analyst price targets sit 216.1% above the current price. Revenue is growing at 639.9%.
Risk comes out at 9 of a possible 10, a high reading. With 30-day volatility of 95.4%, a beta of 2.32 and a maximum drawdown of 81.5%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 90 on the fear-greed composite.
The horizons line up on hold — conviction 1 out of 10.
The company is not currently profitable on a trailing basis, so earnings multiples offer no valuation support. Analyst price targets sit 216.1% above the current price. Revenue is growing at 639.9%.
Risk comes out at 9 of a possible 10, a high reading. With 30-day volatility of 95.4%, a beta of 2.32 and a maximum drawdown of 81.5%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 90 on the fear-greed composite.
The horizons line up on hold — conviction 1 out of 10.
Top Market Events
Vancouver, British Columbia, August 25th, 2026, FinanceWireZenaTech, Inc.SORA-based authorization for ZenaDrone enables the Drone as a Service platform to deliver large-scale precision...ZenaTech, Inc. Nasdaq: ZENA FSE: 49Q BMV: ZENA “ZenaTech” , a technology solution provider specializing in AI...
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 2/10
Key Factors
- Trading below the 200-day average of 2.30
- MACD momentum is negative
- 30-day price change of +12.2%
Medium Term
1–3 yearsNeutral
Model confidence: 1/10
Key Factors
- Trading below the 200-day average of 2.30
- Analyst targets imply +216.1% versus the current price
- 30-day volatility of 95.4%
Long Term
> 3 yearsNeutral
Model confidence: 1/10
Key Factors
- Analyst targets imply +216.1% versus the current price
- Negative return on equity of -132.0%
- Revenue growth of +639.9%
Key Metrics & Analysis
Financial Health
Revenue Growth639.90%
P/E Ratio-3.1
ROE-131.96%
ROA-37.17%
Debt/Equity19.61
P/B Ratio-39.9
Op. Cash Flow$-49393572
Free Cash Flow$-56532908
Industry P/E32.6
Technical Analysis
TrendNeutral
RSI36.2
Support$1.40
Resistance$2.19
MA 20$1.74
MA 50$1.60
MA 200$2.30
MACDBearish
VolumeDecreasing
Fear & Greed Index90.48
Valuation
Target Price$4.50
Upside/Downside216.12%
GradeFair
TypeGrowth
Risk Assessment
Beta2.32
Volatility95.37%
Sector RiskHigh
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.